BPG is committed to discovery and dissemination of knowledge
Articles in Press
6/25/2025 8:26:15 AM | Browse: 34 | Download: 0
Publication Name World Journal of Hepatology
Manuscript ID 108850
Country China
Category Gastroenterology & Hepatology
Manuscript Type Case Control Study
Article Title Evaluating serum extra spindle pole bodies-like 1 protein vs p53 antibody for hepatitis B virus-related hepatocellular carcinoma diagnosis
Manuscript Source Unsolicited Manuscript
All Author List Yan-Fei Feng, Hui-Kun Zhou, Bo-Bin Hu, Hang Wang, Heng-Kai Liang, Lu Wei, Qing-Mei Li, Tu-Mei Su, Qian-Bing Yin, Ming-Hua Su and Jian-Ning Jiang
Funding Agency and Grant Number
Funding Agency Grant Number
National Natural Science Foundation of China No. 81960115, No. 82160123 and No. 82260124
Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor (Guangxi Medical University), Ministry of Education No. GKE-ZZ202107
Guangxi Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor No. GKE-ZZ202218
Guangxi Science and Technology Program No. AD25069077
Corresponding Author Jian-Ning Jiang, Chief Physician, MD, PhD, Professor, Department of Infectious Diseases, The First Affiliated Hospital of Guangxi Medical University, No. 6 Shuangyong Road, Nanning 530021, Guangxi Zhuang Autonomous Region, China. gxjjianning@163.com
Key Words Extra spindle pole bodies-like 1; p53 antibody; Hepatocellular carcinoma; Hepatitis B virus; Diagnostic biomarker; Case-control study
Core Tip This study evaluates serum extra spindle pole bodies-like 1 (ESPL1) protein as a diagnostic biomarker for hepatitis B virus-related hepatocellular carcinoma (HBV-HCC), demonstrating superior sensitivity and accuracy compared to p53 antibody and alpha-fetoprotein (AFP). ESPL1 levels progressively increase from chronic hepatitis B to cirrhosis and HCC, correlating with disease progression. Mechanistically, ESPL1 overexpression due to HBV integration drives chromosomal instability, promoting oncogenesis. These findings support ESPL1 as a promising biomarker for early HBV-HCC detection. The study also suggests that ESPL1 may complement AFP in clinical settings, offering enhanced diagnostic reliability and supporting its potential as a novel candidate for HBV-HCC early detection.
Citation Feng YF, Zhou HK, Hu BB, Wang H, Liang HK, Wei L, Li QM, Su TM, Yin QB, Su MH, Jiang JN. Evaluating serum extra spindle pole bodies-like 1 protein vs p53 antibody for hepatitis B virus-related hepatocellular carcinoma diagnosis. World J Hepatol 2025; In press
Received
2025-04-25 11:07
Peer-Review Started
2025-04-29 00:14
To Make the First Decision
Return for Revision
2025-05-17 08:38
Revised
2025-05-31 01:38
Second Decision
2025-06-25 02:46
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief
2025-06-25 08:26
Articles in Press
2025-06-25 08:26
Publication Fee Transferred
2025-06-04 04:02
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 1948-5182 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com